App-etite for change: a Four-Week feasibility randomised controlled trial of a smartphone application to support adherence to a Mediterranean-Style diet and resistance exercise
NCT ID NCT07885254
First seen Oct 21, 2026 · Last updated Oct 21, 2026
Summary
Eating a Mediterranean-style diet and doing regular resistance training are both known to lower the risk of heart disease. However, most people find it hard to stick to these habits over time, and few smartphone apps support both diet and strength training together. This study tests a smartphone app called MedEx Tracker, which was developed by the research team. The app lets people record what they have eaten against a set of Mediterranean diet targets, record the weight and repetitions for each set of their resistance training, and see how they are doing through a progress screen. It also sends reminders during the day and suggests when to increase training weight. Healthy adults aged 18 to 55 will be randomly assigned to one of two groups. Both groups will be given the same Mediterranean diet targets and the same strength training programme. One group will receive this through the app; the other will receive it as a printed booklet. This means any difference between the groups should be due to the app itself rather than to different advice. Everyone will attend the laboratory before and after the four weeks for measurements and questionnaires. The main aim is to find out whether the app is usable and acceptable to participants, and whether it helps people stick to a Mediterranean-style diet and a resistance training programme. The findings will be used to decide whether the app is suitable for a larger future study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * own and use a smartphone * no contraindication to exercise on a pre-activity readiness questionnaire (PARQ) Exclusion Criteria: * pregnant or nursing * presence of a dietary allergy or food intolerance * adherence to a restrictive diet (keto, carnivore, vegan, vegetarian etc)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy volunteers are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Liverpool John Moores University
Liverpool, Merseyside, L3 3AF, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A phase 1, randomized, Double-Blind, Placebo-Controlled, First-in-Human study to evaluate the safety, tolerability, and pharmacokinetics of single ascending doses of orally administered BMS-986485 in healthy adult participants (Part a), and a conditional open-label study to evaluate the relative bioavailability of alternate formulations of BMS-986485 in healthy adult participants (Part b)
- A phase i clinical study to evaluate the tolerability and pharmacokinetics of recombinant anfibatide injection after single administration in healthy adult subjects
- Acute effects of static stretching, assisted dynamic stretching, kinesio taping, cold water immersion and foam rolling on maximal isometric Wrist-Flexion strength and on precise force and position modulation of the wrist in healthy adults: a randomised Five-Period crossover trial
- Can a ketone drink help your muscles hold onto protein after a workout?
- Can virtual reality lift the mood of older adults in care homes?
- Can a different milk protein ease toddler tummies?